Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsis.
about
Toll-like receptor 4 expression on circulating leucocytes in hemolytic uremic syndrome.Toll-like receptor 4 (TLR4) modulation by synthetic and natural compounds: an update.Evaluation of Toll-like, chemokine, and integrin receptors on monocytes and neutrophils from peripheral blood of septic patients and their correlation with clinical outcomes.TAT-SNAP-23 treatment inhibits the priming of neutrophil functions contributing to shock and/or sepsis-induced extra-pulmonary acute lung injuryIncreased percentages of T helper cells producing IL-17 and monocytes expressing markers of alternative activation in patients with sepsisPatterns of gene expression in peripheral blood mononuclear cells and outcomes from patients with sepsis secondary to community acquired pneumonia.Association between early airway damage-associated molecular patterns and subsequent bacterial infection in patients with inhalational and burn injuryCD66b Overexpression and Loss of C5a Receptors as Surface Markers for Staphylococcus aureus-Induced Neutrophil DysfunctionModulation of monocytes in septic patients: preserved phagocytic activity, increased ROS and NO generation, and decreased production of inflammatory cytokinesEvidence of changes in the immunophenotype and metabolic characteristics (intracellular reactive oxygen radicals) of fetal, but not maternal, monocytes and granulocytes in the fetal inflammatory response syndrome.Identification of sepsis subtypes in critically ill adults using gene expression profilingApocynin and Nox2 regulate NF-κB by modifying thioredoxin-1 redox-state.Flagellin treatment prevents increased susceptibility to systemic bacterial infection after injury by inhibiting anti-inflammatory IL-10+ IL-12- neutrophil polarization.Year in review 2008: Critical Care--sepsisInterference of flavonoids with fluorescent intracellular probes: methodological implications in the evaluation of the oxidative burst by flow cytometry.Inflammasome gene profile is modulated in septic patients, with a greater magnitude in non-survivors.HLA-DR expression, cytokines and bioactive lipids in sepsis.Reactive oxygen species measure for rapid detection of infection in fluids.CD163 and CD206 expression does not correlate with tolerance and cytokine production in LPS-tolerant human monocytes.Marked alterations of neutrophil functions during sepsis-induced immunosuppression.Kinetics of leukocyte CD11b and CD64 expression in severe sepsis and non-infectious critical care patients.Human monocytes tolerant to LPS retain the ability to phagocytose bacteria and generate reactive oxygen species.Lipopolysaccharide-induced expression of cell surface receptors and cell activation of neutrophils and monocytes in whole human blood.Functional heterogeneity and differential priming of circulating neutrophils in human experimental endotoxemia.Analysis of the temperature affects on leukocyte surface antigen expression.Effects of 47C allele (rs4880) of the SOD2 gene in the production of intracellular reactive species in peripheral blood mononuclear cells with and without lipopolysaccharides induction.Proteomic study revealed cellular assembly and lipid metabolism dysregulation in sepsis secondary to community-acquired pneumonia.
P2860
Q33397459-9E6A5FB4-8468-45A4-BA5F-56ECC7BB19E8Q33693637-277FCB60-06D1-46B7-BA8D-9E3558D5A1E9Q33822199-0DA9797F-8882-4EEC-8FD6-EBA6BC90918CQ33882421-CCEE0023-9A75-42A3-A5B3-3B3528893234Q34302328-A5FF6CE7-D411-4A40-AE3B-6A006D9D746DQ35131265-4CA87B21-A93E-4381-BB2E-9C3BD9B0DE3BQ35574722-30C80ABB-E907-40F8-8157-E39E1344C09FQ35692025-470C194A-F3A9-44F5-9509-14BA284EE3E4Q36581980-E124577E-2B2D-4F41-B27D-CA572758D18DQ36677529-C84F6AD0-690E-41C6-88C2-1B36342ED556Q36928191-4ADF17AD-A3AA-4FF0-BA2B-16EC2F43490AQ37307363-292B89B5-FA6D-4B65-866F-6BFEEB3A373CQ37484450-965D0B0C-9450-4A9D-B2ED-5F20F942D78CQ37626881-A6304AE1-6B01-4D89-B380-E2A851ED7471Q38216941-28ACDF1B-A4F2-4CC7-9204-3461AE8F2087Q38709229-CE6AA17C-EA12-451E-8A35-ED3A9A8E57F1Q40184801-740AC6EC-A4B4-4489-B575-231B8E6A5A18Q40693331-65552169-51B4-4F68-B23D-1D73682B9798Q41008875-9055833D-18B9-436F-B415-046165A3BCA4Q41082527-6A52082B-3AD3-4E1E-81C5-DEE5DAA82AEDQ41340169-F0FD30CB-769B-4DF0-9F28-7216CB4FC5A0Q42929674-66F49E9D-CC2A-47D8-B6D6-3B9EB92A55FFQ42933177-E39D5474-88FC-4E66-A43B-49EBAAEED63BQ43094851-8EA76958-53E4-465C-84B3-5074D84B81DBQ44448837-0782B82E-5466-426D-A375-E3CA5C53DAADQ46897374-8C1979CB-3F58-4AD6-B327-F8F921167BA3Q47398299-E89398C1-7F16-4AE1-9167-54FF0CAD3545
P2860
Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Expression of cell surface rec ...... clinical continuum of sepsis.
@ast
Expression of cell surface rec ...... clinical continuum of sepsis.
@en
type
label
Expression of cell surface rec ...... clinical continuum of sepsis.
@ast
Expression of cell surface rec ...... clinical continuum of sepsis.
@en
prefLabel
Expression of cell surface rec ...... clinical continuum of sepsis.
@ast
Expression of cell surface rec ...... clinical continuum of sepsis.
@en
P2093
P2860
P50
P356
P1433
P1476
Expression of cell surface rec ...... e clinical continuum of sepsis
@en
P2093
Flavia R Machado
Leandro S W Martos
Paulo S Martins
Sergio Blecher
P2860
P2888
P356
10.1186/CC6801
P577
2008-02-13T00:00:00Z
P5875
P6179
1053501032